William Sipprell, MD
MOHS-Micrographic Surgery · Victor, NYNPI 1699182881
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $466 of the $566 with a category attached, or 82.3%. 9 manufacturers reported payments, led by Johnson & Johnson at 24.1% of the total. That places this record below the midpoint for mohs-micrographic surgery clinicians in NY, where the typical reported total is $1,291.
Across 16 payments — averaging $35.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$136
- Galderma Laboratories, L.p.$112
- Sanofi$98
- AbbVie$84
- Novartis$45
- Regeneron Healthcare Solutions, Inc.$36
- plus $55 from 3 others
Across 9 payments — averaging $162.41 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$1K
What the payments were for
- Food & beverage$46682%
- Education$10018%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 2 | $136 |
| Galderma Laboratories, L.p. | 1 | $112 |
| Sanofi | 3 | $98 |
| AbbVie | 4 | $84 |
| Novartis | 2 | $45 |
| Regeneron Healthcare Solutions, Inc. | 1 | $36 |
| Lilly USA, LLC | 1 | $21 |
| Biofrontera Inc. | 1 | $20 |
| Botanix SB Inc | 1 | $14 |
How this compares
$566 in reported general payments places this provider in the 30th percentile of 75 mohs-micrographic surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Acitretin | 16 | $3,989 |
| Cefadroxil | 42 | $356 |
| Triamcinolone Acetonide | 13 | $148 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Victor
- Sherrif IbrahimVictor$412K
- Daniel SiegelSmithtown$450K
- Kavita MariwallaWest Islip$221K
- Ellen MarmurNew York$186K
- Kenneth MarkSouthampton$91K
- Michael TassavorNew York$55K
- Jane YooNew York$42K
- Hamza BhattiNew York$40K
- Desiree RatnerNew York$32K
- Eyal LevitBrooklyn$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.